This page contains brief information about dactinomycin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Dactinomycin is approved to be used alone or with other drugs to treat:
- Ewing sarcoma.
- Gestational trophoblastic disease.
- Rhabdomyosarcoma in children.
- Solid tumors. It is used as palliative and/or adjuvant therapy for disease that has recurred (come back).
- Testicular cancer. It is used for nonseminomas that have metastasized (spread to other parts of the body).
- Wilms tumor.
Dactinomycin is also being studied in the treatment of other types of cancer.
More About Dactinomycin
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
MedlinePlus Information on Dactinomycin – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Dactinomycin – Check for trials from TCH’s list of cancer clinical trials now accepting patients.